At Oncoleader, we’re not just observing the industry, we’re investigating it, analyzing its trends, and telling its stories. From unlicensed technologies to stealth-stage startups, we help our partners understand, frame, and act on what’s happening next.
The Oncoleader platform powers two distinct but connected service offerings:
Flyte Bio: Strategic Communications for Emerging Biotech
Flyte Bio is our communications and investor strategy studio. We partner with early-stage biotech companies to build narratives that resonate strongly with investors, partners, and the public.
Hazeon Catalyst works upstream – at the intersection of academic discovery and venture creation. We help VCs, tech transfer offices, and scientific founders identify, evaluate, and translate high-potential oncology IP.